drugset / Trial / NCT01984255
A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a Open label, two-arm, randomized, two agent, single center trial.
Timeline
- Start
- 2014-04
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bavituximab | Monoclonal antibody | 3 mg/kg | Intravenous |
| Subject | Ipilimumab | Monoclonal antibody | 3 mg/kg | Intravenous |